Last $6.93 USD
Change Today -0.12 / -1.70%
Volume 139.7K
ACTC On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
As of 5:20 PM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carol A. Tauer Ph.D.

Member of Ethics Advisory Board, Advanced Cell Technology Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Carol A. Tauer, Ph.D. is Professor of Philosophy Emerita at the College of St. Catherine in St. Paul, Minnesota and is Visiting Professor at the Center for Bioethics. Ms. Tauer serves as Member of Ethics Advisory Board of Advanced Cell Technology Inc. Ms. Tauer was a member of the NIH Human Embryo Research Panel that was charged to make ethical recommendations for federal funding of research on infertility, preimplantation diagnosis, and stem cell research since 1994 ...

Read Full Background

Corporate Headquarters*

33 Locke Drive
Marlborough, Massachusetts 01752

United States

Phone: 508-756-1212
Fax: 508-229-2333

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Massachusetts Institute of Technology
PhD
Georgetown University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACTC:US $6.93 USD -0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Olav Hellebo Chief Executive Officer
ReNeuron Group plc
--
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, General Counsel and Director
Neuralstem, Inc.
$651.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVANCED CELL TECHNOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.